Publications by authors named "Lydia Fischbuch"

Claim this Profile
A
Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx).
Gil Awada, Laila Ben Salama, Jennifer De Cremer, Julia Katharina Schwarze, Lydia Fischbuch

J Immunother Cancerยท October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis